In Situ Transition of Amorphous Carbon to Graphite-like Structures Using MXene as a Template for Fast and Long-Lasting Macrosuperlubricity by Kaihuan Yu (9111978)

Image_3_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

“…Previous studies were based on limited data sources and had a narrow geographical scope. We aim to understand the trends of alteration in the burden of neonatal disorders from 1990 to 2019 in 204 countries and territories.…”

Image_4_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

“…Previous studies were based on limited data sources and had a narrow geographical scope. We aim to understand the trends of alteration in the burden of neonatal disorders from 1990 to 2019 in 204 countries and territories.…”

Image_5_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

“…Previous studies were based on limited data sources and had a narrow geographical scope. We aim to understand the trends of alteration in the burden of neonatal disorders from 1990 to 2019 in 204 countries and territories.…”

Image_1_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

“…Previous studies were based on limited data sources and had a narrow geographical scope. We aim to understand the trends of alteration in the burden of neonatal disorders from 1990 to 2019 in 204 countries and territories.…”

Image_7_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

“…Previous studies were based on limited data sources and had a narrow geographical scope. We aim to understand the trends of alteration in the burden of neonatal disorders from 1990 to 2019 in 204 countries and territories.…”

Image_2_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

“…Previous studies were based on limited data sources and had a narrow geographical scope. We aim to understand the trends of alteration in the burden of neonatal disorders from 1990 to 2019 in 204 countries and territories.…”

Image_6_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

“…Previous studies were based on limited data sources and had a narrow geographical scope. We aim to understand the trends of alteration in the burden of neonatal disorders from 1990 to 2019 in 204 countries and territories.…”

Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children by Charles Arama (159942)

Effect of different polyunsaturated fatty acids (PUFAs) in the inhibition of HCoV-229Eviral replication in MRC5 cells using antibody-based assay demonstrates significant inhibition... by Amanda Watson (4447267)

Data_Sheet_1_Microplastic Monitoring at Different Stages in a Wastewater Treatment Plant Using Reflectance Micro-FTIR Imaging.PDF by Alexander S. Tagg (9133388)

“…Despite the marked reduction in the number of MP particles following the primary settlement stage, an average total of 1.5 MP L^–1 were identified in the final effluent of the WWTP.…”

Image_1_Citrulline and ADI-PEG20 reduce inflammation in a juvenile porcine model of acute endotoxemia.jpeg by Caitlin Vonderohe (19350625)

Image_2_Citrulline and ADI-PEG20 reduce inflammation in a juvenile porcine model of acute endotoxemia.jpeg by Caitlin Vonderohe (19350625)

Image_3_Citrulline and ADI-PEG20 reduce inflammation in a juvenile porcine model of acute endotoxemia.jpeg by Caitlin Vonderohe (19350625)

Table 1_Association between androgenetic alopecia and psychological well-being: a systematic review and meta-analysis.docx by Yuan Kong (110669)

“…Background<p>Androgenetic alopecia (AGA) is a prevalent chronic condition with health burden, yet its association with psychological well-being remains inconsistent. …”

Table2_Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study.docx by Wei Cheng (52808)

“…Minimum clinically important difference (MCID) was defined as attaining a COPD assessment test (CAT) decrease ≥2. We mainly assessed the MCID and the incidence of exacerbations at the 6 months follow-up.…”

Table1_Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study.docx by Wei Cheng (52808)

“…Minimum clinically important difference (MCID) was defined as attaining a COPD assessment test (CAT) decrease ≥2. We mainly assessed the MCID and the incidence of exacerbations at the 6 months follow-up.…”

Table3_Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study.docx by Wei Cheng (52808)

“…Minimum clinically important difference (MCID) was defined as attaining a COPD assessment test (CAT) decrease ≥2. We mainly assessed the MCID and the incidence of exacerbations at the 6 months follow-up.…”

Figure S1 - Electrical Stimuli Are Anti-Apoptotic in Skeletal Muscle via Extracellular ATP. Alteration of This Signal in Mdx Mice Is a Likely Cause of Dystrophy by Denisse Valladares (489234)

“…</b> Normal and dystrophic muscle fibers were stimulated with different concentrations of external ATP and mRNA levels of Bax were measured 1 h after ATP addition (A and C). We observed the maximum decrease in mRNA levels when using a concentration of 100 µM in normal fibers (A), while the maximum values were found for 50 and 100 µM in dystrophic fibers (B) (n = 4). …”

Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis by Ning Xia (196015)

“…Compared with placebo, inhaled LABAs significantly decreased fatal cardiovascular adverse events in COPD patients (RR 0.65, 95% CI 0.50 to 0.86, P = 0.002). …”